Bertrand Magy is the founder of ATB Therapeutics. ATB Therapeutics has raised $59M in total funding. Latest round: Series A. Backed by EQT Life Sciences.
Bertrand Magy is the Co-founder and former CEO of ATB Therapeutics, a Belgian biopharmaceutical company developing antibody-based therapies. He founded the company in 2018 and led it through its seed financing rounds and into its Series A growth phase. In 2025, Magy transitioned to a non-CEO leadership role within the company.
Full founder directory · Investor directory · Company funding database · Fundraising library